While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
A Congressional Budget Office (CBO) document released quietly on Thursday hinted at a major gaffe by the budget agency and its efforts to conceal that gaffe.
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
We want success, and productive work requires focus. If you’re a rich kid micro-dosing amphetamines for school or career advantage, that’s rewarded.
By throwing money at the problem of rising drug costs, Republican leaders’ ‘solution’ may end up raising them even faster.
A major anti-addiction nonprofit organization is getting big bucks from the pharmaceutical industry. Whose interests are the American Society of Addiction Medicine serving?
Danish researchers have found there are approximately 13 additional breast cancer cases for every 100,000 women who use hormonal contraception for one year.
The opioid epidemic has taken the lives of more than 300,000 Americans since 2000. Cooperation between the United States and China is a key element to fight back.
The rising costs of many, if not all, medications are largely the result of the lack of competition in the pharmaceutical industry. That’s the FDA’s fault.
We could have increased access, improved quality, and decreased costs with better medical licensing, prescription drug regulation, Food and Drug Administration approval, and patent law.
Despite our ridiculous current debate, you can save hundreds, even thousands, of dollars tomorrow, doing the same things you do with every other product you shop for.
To date, research shows marijuana-based chemical compounds can be everything from anti-inflammatory to neuroprotective, with fewer side effects than pain drugs.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
With his experience and highly competent past FDA leadership, Trump nominee Scott Gottlieb will oversee all the FDA divisions with better scrutiny than the prior commissioner did.
If the president was truly concerned with solving the program, he would ditch the talking points and instead focus on what is needed to bring costs down.
With a press hell-bent on inciting, Marathon was an easy target. Once the flames picked-up a head wind over the Capitol, it had little choice but to pull back and dig a fire line.
The Left insists that the 21st Century Cures Act’s regulatory updates to allow high-need patients to try out new drugs will mean more death and suffering. In fact, the opposite is true.
It’s easy to dismiss these side effects as trivial, and to laugh at men for being weaklings. But the potential side effects were dangerous, and women should not accept them, either.
- DOJ Frets About Source Outing While Deliberately Outing SourceFederal officials have provided more information to repcontinue reading >
- One Year In, The Russia Investigations Keep Leading Back To The InvestigatorsWhat was once a no-downside case for Special Counsel Rocontinue reading >
- Media Choose To Defend MS-13 Instead Of Acknowledging Misleading Reporting On TrumpTrump was criticized for referring to members of MS-13 continue reading >